Prenatal infection and schizophrenia: A decade of further progress.

Prenatal infection and schizophrenia: A decade of further progress.
复制标题

DOI:
10.1016/j.schres.2021.05.014
复制
发表时间:
2022-09
影响因子:
4.5
通讯作者:
Brown AS
Brown AS
中科院分区:
医学2区
文献类型:
--
作者:
Cheslack-Postava K;Brown AS

文献摘要

参考文献

被引文献

相似文献

Epidemiologic studies have provided evidence that prenatal exposure to maternal infection is associated with an increased risk of developing schizophrenia in the offspring. Research over the past decade has added further to our understanding of the role of prenatal infection in schizophrenia risk. These investigations include several well-powered designs, and like some earlier studies, measured maternal antibodies to specific infectious agents in stored serum samples and large registers to identify clinically diagnosed infections during pregnancy. Convergent findings from antibody studies suggest that prenatal maternal infection with Toxoplasma gondii is associated with increased schizophrenia risk in the offspring, while associations with HSV-2 infection are likely attributable to confounding. Maternal influenza infection remains a viable candidate for schizophrenia, based on an early serological study, though there has been only one attempt to replicate this finding, with a differing methodology. A prior association between maternal serologically confirmed cytomegalovirus infections require further study. Clinically diagnosed maternal infection, particularly bacterial infection, also appears to be associated with increased risk of offspring schizophrenia, and heterogeneity in these findings is likely due to methodological differences between studies. Further clarification may be provided by future studies that address the timing, type, and clinical features of infections. Important insight may be gained by examining the long-term offspring outcomes in emerging epidemics such as Zika virus and COVID-19, and by investigating the interaction between exposure to prenatal infection and other risk or protective factors.
DOI: 10.1093/schbul/sbv112
发表时间: 2016-01-01
影响因子: 6.6
作者:
Blomstrom, Asa;Karlsson, Hakan;Dalman, Christina
通讯作者: Dalman, Christina
DOI: 10.1006/brbi.2001.0644
发表时间: 2001-12-01
影响因子: 15.1
作者:
Buka, SL;Tsuang, MT;Yolken, RH
通讯作者: Yolken, RH
DOI: 10.1093/schbul/sby058
发表时间: 2018-11-01
影响因子: 6.6
作者:
Charlson, Fiona J.;Ferrari, Alize J.;Whiteford, Harvey A.
通讯作者: Whiteford, Harvey A.
DOI: 10.1176/appi.ajp.2013.13070943
发表时间: 2014-05
期刊: The American journal of psychiatry
影响因子: --
作者:
Canetta SE;Bao Y;Co MD;Ennis FA;Cruz J;Terajima M;Shen L;Kellendonk C;Schaefer CA;Brown AS
通讯作者: Brown AS
DOI: 10.1093/schbul/sbw083
发表时间: 2017-01-01
影响因子: 6.6
作者:
Debost, Jean-Christophe P. G.;Larsen, Janne Tidselbak;Petersen, Liselotte
通讯作者: Petersen, Liselotte